Real-world Study Comparing the Adherence and Effectiveness of Linagliptin vs. Acarbose
Condition: Diabetes Mellitus, Type 2 Interventions: Drug: Linagliptin; Drug: Acarbose Sponsor: Boehringer Ingelheim Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials